GRB7 and familial pancreatic carcinoma: These interactions may underlie the observed inhibition of breast cancer cell proliferation and decrease in cell migration of pancreatic cancer cells treated with G7-18NATE, making it of considerable importance to further characterise this peptide and its interactions with Grb7 SH2 domain.